Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026
Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026...
Yahoo! Finance: News
More News
Taysha Gene Therapies (NASDAQ:TSHA) Issues Earnings Results
Taysha Gene Therapies (NASDAQ:TSHA - Get Free Report) released its earnings results on Wednesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.02...
MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High - Here's What Happened
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - What's Next...
MarketBeat
Taysha Gene Therapies (TSHA) to Release Earnings on Wednesday
Taysha Gene Therapies (NASDAQ:TSHA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-taysha-gene-therapies-inc-stock...
MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High - Should You Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened...
MarketBeat
Taysha Gene Therapies Sees Unusually High Options Volume (NASDAQ:TSHA)
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) was the target of some unusual options trading on Thursday. Stock investors acquired 6,277 call options on the company. This is an increase...
MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Sets New 12-Month High - Still a Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 52-Week High - What's Next...
MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 9% - Should You Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 9% - Still a Buy...
MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Brokerages
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has received an average rating of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities...
MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells $892,000.00 in Stock
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an...
MarketBeat
<
1
2
>

Advertisement|Remove ads.